KALA BIO
KALA
25 hedge funds and large institutions have $14.8M invested in KALA BIO in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
204% more capital invested
Capital invested by funds: $4.88M → $14.8M (+$9.95M)
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
51.25% more ownership
Funds ownership: 22.93% → 74.18% (+51%)
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
14% more funds holding
Funds holding: 22 → 25 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$4.13M |
| 2 |
SOCM
SR One Capital Management
Wayne,
Pennsylvania
|
+$2.93M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$2.02M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$496K |
| 5 |
VF
Virtu Financial
New York
|
+$206K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$106K |
| 2 |
Renaissance Technologies
New York
|
-$91K |
| 3 |
BlackRock
New York
|
-$38.7K |
| 4 |
KOCAA
Knights of Columbus Asset Advisors
New Haven,
Connecticut
|
-$19.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14.2K |
KALA Hedge Fund Activity: Q2 2024 in Review
25 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2024, worth a combined $14.8M — up 204% from $4.88M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new KALA positions and 4 closed out — a net gain of 3 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $4.13M. The largest seller was Citadel Advisors, exiting entirely with an estimated $106K sold.
- 25 institutional investors held KALA BIO (KALA) as of Q2 2024, up from 22 in Q1 2024.
- Funds reported $14.8M of KALA BIO stock for Q2 2024, up 204% quarter-over-quarter.
- 7 funds opened new KALA BIO positions in Q2 2024 and 4 closed out, a net change of +3 holders.
- The largest KALA BIO buyer in Q2 2024 was Baker Bros. Advisors, an estimated $4.13M added.
- The largest KALA BIO seller in Q2 2024 was Citadel Advisors, an estimated $106K sold.
Based on aggregated 13F filings for Q2 2024.